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ABSTRACT
Objective: To evaluate the association of the degree of gingival inflammation and 25-hydroxy Vitamin D (25(OH)D) level in postmenopausal women.
Methods: A cross-sectional study involved 71 postmenopausal women. Data were obtained using questionnaires, clinical periodontal examinations, 
and evaluations of blood samples. Serum 25(OH)D concentrations were determined using human 25-dihydroxy Vitamin D ELISA kit.
Result: Prevalence of Vitamin D deficiency among postmenopausal women was 74.64%. The papillary bleeding index (PBI) was lower (1.07±0.18) in 
postmenopausal women with normal serum 25(OH)D levels than that in postmenopausal women with Vitamin D deficiency (1.41±0.1). However, this 
difference was not statistically significant (p<0.05). This result indicated increasing trends in PBI.
Conclusion: There is no association between the degree of gingival inflammation and the 25(OH)D status among postmenopausal women.
Keywords: 25-hydroxy Vitamin D, Papillary bleeding index, Postmenopause.
INTRODUCTION
Menopause is defined as the cessation of menstruation for at least 
1 year due to estrogen deficiency. A considerable proportion of the 
population is affected by estrogen deficiency; there are approximately 
70 million women in the United States >50 years of age [1]. It is 
estimated that there will be 60 million menopausal women in Indonesia 
by 2025. Currently, in Indonesia, there are 14 million menopausal 
women, comprising 7.4% of the total population [2]. Multiple health 
issues affect postmenopausal women and compromise their quality 
of life. Postmenopausal women may experience several symptoms [3], 
including cardiovascular disease, osteoporosis, cancer, cognitive 
decline and dementia, chronic obstructive pulmonary disease, diabetes 
mellitus, metabolic syndrome, depression, vasomotor symptoms, sleep 
disturbances, and migraine [3,4].
Vitamin D and calcium are the basic requirements for bone 
mineralization and osteoporosis prevention [5]. Vitamin D plays an 
important role in calcium homeostasis, promoting calcium absorption 
in the intestines, and stimulating the osteoblasts to enable normal 
bone growth and preservation [6,7]. Low Vitamin D and calcium 
intake lead to a negative calcium balance and bone loss; these effects 
are also believed to occur in the alveolar bone in addition to that in 
the other bones of the body [7]. Vitamin D formed in the skin and that 
obtained from the diet is absorbed and accumulates in the liver where 
it undergoes hydroxylation and metabolization to form 25-hydroxy 
Vitamin D (25(OH)D), also called calcidiol, the levels of which are used 
to determine an individual’s Vitamin D status [8].
Periodontal disease results in the destruction of the supporting 
structures of the teeth by an inflammatory process caused by bacterial 
accumulation on the hard surfaces of the teeth [9].
Vitamin D plays a significant role in bone maintenance and immunity; 
therefore, it can be inferred that Vitamin D influences the development 
of periodontal disease [9]. Vitamin D also has anti-inflammatory and 
antimicrobial properties that may protect against alveolar bone loss 
and subsequent tooth loss [10]. Vitamin D deficiency may result in an 
inadequate and prolonged immune reaction to periodontal pathogens, 
potentially leading to more severe periodontal destruction [9]. To the 
best of our knowledge, few researches have been conducted on the 
association between the degree of gingival inflammation and Vitamin D 
status in postmenopausal women.
The purpose of this study was to evaluate the association between the 




Approval for the study on human subjects was obtained from the Ethics 
Committee of the Faculty of Dentistry, Universitas Indonesia, before 
study initiation. The sample size calculations were performed using the 
sample formula for cross-sectional study design, according to which at 
least 59 subjects needed to be enrolled. The research procedures were 
explained to all patients after they had read and signed an informed 
consent document before any treatment.
The investigator screened the patients according to the inclusion and 
exclusion criteria and selected those who fulfilled the study criteria. 
Women, aged 50–70 years, who had entered the menopause period 
(calculated after 1 year of the last menstrual cycle), had no systemic 
diseases that could influence the outcomes of the therapy, and were 
willing and able to provide an informed consent were enrolled in the 
study. Subjects on antibiotic therapy for more than 10 days within the 
past 3 months of enrollment or those requiring antibiotic prophylaxis, 
subjects on medications affecting bone metabolism or gingiva, or those 
with a history of hysterectomy were excluded. Information regarding 
the subjects’ medical histories and medications were collected using 
a questionnaire [11]. The questionnaire included questions about 
the physical activity, calcium intake, and sun exposure [11]. Total 71 
patients, all of whom were citizens recruited from the Kenari District 
Office, Central Jakarta, were enrolled in the study.
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Clinical periodontal examination
The periodontal status was assessed by measuring the papillary 
bleeding index (PBI) (Muhlemann, 1977) [12]. Clinical measurements 
were recorded by the calibrated investigator using a periodontal probe 
with 1 mm markings (Osung, Korea). Calibration was conducted by 
performing double measurements of a randomly selected patient not 
involved in the study. Third molars were not included in the clinical 
assessment because of the substantial variation in their anatomy and 
position in the oral cavity.
Laboratory analysis
A venous blood sample was drawn from each subject on the day of the 
examination. Serum samples were separated after centrifugation at 
3000 rpm for 10 min; thereafter, they were stored at −4°C until further 
assays. These samples were removed from the freezer and defrosted at 
room temperature before the assays.
All assays were performed in the Integrated Laboratory Faculty of 
Medicine Universitas Indonesia. Serum 25(OH)D was analyzed using a 
commercially available enzyme-linked immunoassay (human 25(OH)
D ELISA Kit, Qayeebio, Shanghai) according to the manufacturer’s 
instructions. The results are expressed as nanogram per milliliter 
(range: 7.8–500 ng/mL). For this study, Vitamin D levels were 
categorized as deficient if the levels were <30 ng/mL and adequate 
if the levels were ≥30 ng/mL, as per the guidelines of the Institute of 
Medicine [13-15].
Statistical analyses
All statistical analyses were performed using SPSS. Univariate analyses 
were performed to obtain the mean and standard deviation values of all 
parameters. Descriptive statistics were obtained, and data were tested 
for normality using the Kolmogorov–Smirnov test for distribution. 
Variables that conformed to a normal distribution were analyzed using 
independent T-tests, while those that showed considerable deviation 
from the normal distribution were analyzed using the Mann–Whitney 
U test and Kruskal–Wallis test to evaluate the statistical significance 
of the differences between the two groups. p<0.05 was considered 
statistically significant.
RESULTS
The distribution of the baseline characteristics of the study population 
is shown in Table 1.
The tests for normality of the clinical parameters of the postmenopausal 
women were performed using Shapiro-Wilk test. These tests showed 
that the distribution of the serum 25(OH)D levels across age, use of veil, 
and menopause duration was abnormal (p=0.02, p=0.00, and p=0.00, 
respectively).
Table 2 summarizes that there were no significant differences in the 
serum 25(OH)D levels across age (p=0.61); use of veil (p=0.71); and 
menopause duration (p=0.17) among postmenopausal women.
The Shapiro–Wilk test was used to test the normality of the clinical 
parameters of the postmenopausal women. The result showed that 
the distribution of serum 25(OH)D levels as per sun exposure was 
abnormal (p=0.01). The normality test showed that the distribution of 
PBI was normal (p=0.33).
This table summarizes that there were no significant differences in the 
25(OH)D status of the postmenopausal women, depending on their sun 
exposure (p=0.68) and PBI (p=0.12) (Table 3).
DISCUSSION
The supporting tissue of the periodontium is vulnerable to the 
physiological variations in the levels of circulating hormones in women. 
Menopause triggers numerous changes in women’s bodies, and the 
oral cavity is also affected [16]. Postmenopausal women are at risk of 
Vitamin D deficiency. The findings of this study showed that 74.64% of 
postmenopausal women had Vitamin D deficiency (Table 1). Ragab et al. 
also reported similar results; 68.6% of the healthy postmenopausal 
women in their study had Vitamin D deficiency [17]. Yared et al.’s study 
on postmenopausal Lebanese women with osteoporosis showed a 
prevalence of 84.9% for Vitamin D deficiency [18].
Table 1: Demographic, clinical, and laboratory characteristics of 
postmenopausal women






Serum 25 (OH) D (ng/ml)
Normal (≥30 ng/ml) 18 (25.35)







Sun exposure (min/week)* 15.52 (2.42)
PBI* 1.33 (0.09)
*Data are presented as mean and standard deviation. SD: Standard deviation, 
PBI: Papillary bleeding index
Table 2: Comparative analysis of the serum 25(OH) D levels 
across age, use of veil, and menopause duration among 
postmenopausal women















*Kruskal–Wallis test, **Mann–Whitney test; p<0.05 significant. SD: Standard 
deviation
Table 3: Comparative analysis of the association of sun exposure 











Sun exposure  
(min/week)
16.06 (3.95) 15.33 (2.97) 0.68*
PBI 1.07 (0.18) 1.41 (0.10) 0.12**
*Mann–Whitney test, **independent sample t-test, p<0.05 significant. 
SD: Standard deviation, PBI: Papillary bleeding index
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The high prevalence of Vitamin D deficiency among the women in our 
study may be because many women cover most of their bodies, considering 
that most of them were Muslim and that most of them wear a veil. In the 
present study, 60.6% of the postmenopausal women reported wearing a 
veil (Table 1), and those who wear veils had lower serum 25(OH)D levels 
(28.6 ± 2.06 ng/dL) than those who do not wear veils (30.9±2.21 ng/dL). 
However, this difference was not statistically significant (Table 2).
This study showed that the women with normal 25(OH)D levels (16.06 
± 3.95 min/week) tended to have longer sun exposure than those with 
Vitamin D deficiency (15.33 ± 2.97 min/week); however, this difference 
was not statistically significant (Table 3). The major source of Vitamin D 
is exposure to natural sunlight. Vitamin D produced in the skin lasts at 
least twice as long in the blood as the ingested Vitamin D [19]. However, 
topical sunscreen application, increased skin pigmentation, and obesity 
can substantially reduce Vitamin D synthesis [19].
This study evaluated the association between the degree of gingival 
inflammation and the 25(OH)D levels in postmenopausal women. The 
findings from this study demonstrated that the PBI was lower in the women 
with normal or adequate serum 25(OH)D levels (1.07±0.18 ng/mL) than 
in those with Vitamin D deficiency (1.41±0.1 ng/mL). However, this 
difference was not statistically significant (Table 3). Vitamin D deficiency 
plays a role in dental and oral bone pathologies (altered formation, 
periodontal disease, and jaw osteonecrosis) [13].
Another study has reported that optimal serum Vitamin D levels may 
reduce an individual’s susceptibility to gingival inflammation and 
that gingivitis may be a useful clinical indicator to evaluate the anti-
inflammatory effects of Vitamin D [20]. This finding was supported by 
the results of a more recent randomized clinical trial that showed a dose-
dependent anti-inflammatory effect of Vitamin D on gingivitis [21].
Further, Vitamin D may also reduce periodontal disease through its 
general anti-inflammatory and immunomodulatory effects [22]. For 
example, the Vitamin D receptor is expressed on several human immune 
cells, decreases the proliferation of the T and B lymphocytes, and 
inhibits the T-helper (Th1) and Th17 (proinflammatory) cell response, 
while promoting a Th2 (anti-inflammatory) cell response [23]. Vitamin 
D may help suppress local inflammation at the site of an oral infection.
This study has some potential limitations that need to be considered. 
First, the lack of an association between the Vitamin D statue sizes. 
Second, the validity of the results is also dependent on the correct 
answers being given by the respondents in the questionnaire rather 
than only on the clinical evaluations and the medical history. The use of 
questionnaires has been validated in several studies [11].
CONCLUSION
There was no association between gingival inflammation and 25(OH)D 
status among the postmenopausal women in this research.
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